229 related articles for article (PubMed ID: 21406335)
21. Microarray analysis of gene expression by microdissected epidermis and dermis in mycosis fungoides and adult T-cell leukemia/lymphoma.
Hashikawa K; Yasumoto S; Nakashima K; Arakawa F; Kiyasu J; Kimura Y; Saruta H; Nakama T; Yasuda K; Tashiro K; Kuhara S; Hashimoto T; Ohshima K
Int J Oncol; 2014 Sep; 45(3):1200-8. PubMed ID: 24970722
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA expression profiling and DNA methylation signature for deregulated microRNA in cutaneous T-cell lymphoma.
Sandoval J; Díaz-Lagares A; Salgado R; Servitje O; Climent F; Ortiz-Romero PL; Pérez-Ferriols A; Garcia-Muret MP; Estrach T; Garcia M; Nonell L; Esteller M; Pujol RM; Espinet B; Gallardo F
J Invest Dermatol; 2015 Apr; 135(4):1128-1137. PubMed ID: 25405321
[TBL] [Abstract][Full Text] [Related]
23. Immune function abnormalities in peripheral blood mononuclear cell cytokine expression differentiates stages of cutaneous T-cell lymphoma/mycosis fungoides.
Chong BF; Wilson AJ; Gibson HM; Hafner MS; Luo Y; Hedgcock CJ; Wong HK
Clin Cancer Res; 2008 Feb; 14(3):646-53. PubMed ID: 18245523
[TBL] [Abstract][Full Text] [Related]
24. Gene Expression Profiling of Mycosis Fungoides in Early and Tumor Stage-A Proof-of-Concept Study Using Laser Capture/Single Cell Microdissection and NanoString Analysis.
Lai J; Li J; Gniadecki R; Lai R
Cells; 2021 Nov; 10(11):. PubMed ID: 34831413
[TBL] [Abstract][Full Text] [Related]
25. Dysregulation of Plasma miR-146a and miR-155 Expression Profile in Mycosis Fungoides Is Associated with rs2910164 and rs767649 Polymorphisms.
Avgeros C; Patsatsi A; Dimitriadis D; Malousi A; Koletsa T; Papathemeli D; Syrnioti A; Avgerou P; Lazaridou E; Tzimagiorgis G; Georgiou E
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613718
[TBL] [Abstract][Full Text] [Related]
26. A meta-analysis of gene expression data identifies a molecular signature characteristic for tumor-stage mycosis fungoides.
van Kester MS; Borg MK; Zoutman WH; Out-Luiting JJ; Jansen PM; Dreef EJ; Vermeer MH; van Doorn R; Willemze R; Tensen CP
J Invest Dermatol; 2012 Aug; 132(8):2050-9. PubMed ID: 22513784
[TBL] [Abstract][Full Text] [Related]
27. Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides.
Fraser-Andrews EA; Mitchell T; Ferreira S; Seed PT; Russell-Jones R; Calonje E; Whittaker SJ
Br J Dermatol; 2006 Oct; 155(4):756-62. PubMed ID: 16965425
[TBL] [Abstract][Full Text] [Related]
28. miRNA in mycosis fungoides and skin inflammation.
Persson JL
APMIS; 2013 Nov; 121(11):1017-9. PubMed ID: 24106870
[TBL] [Abstract][Full Text] [Related]
29. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
[TBL] [Abstract][Full Text] [Related]
30. Analysis of beta, gamma, and delta T-cell receptor genes in mycosis fungoides and Sezary syndrome.
Whittaker SJ; Smith NP; Jones RR; Luzzatto L
Cancer; 1991 Oct; 68(7):1572-82. PubMed ID: 1654197
[TBL] [Abstract][Full Text] [Related]
31. Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic nevi.
Sand M; Skrygan M; Sand D; Georgas D; Gambichler T; Hahn SA; Altmeyer P; Bechara FG
Cell Tissue Res; 2013 Jan; 351(1):85-98. PubMed ID: 23111773
[TBL] [Abstract][Full Text] [Related]
32. Determination of T-cell clonality and expression profiles of Toll-like receptors signaling pathway genes and related miRNAs in patients with mycosis fungoides.
Seçme M; Dodurga Y; Demirkan NÇ; Kaçar N; Günel NS; Açıkbaş İ
Gene; 2024 Jan; 891():147825. PubMed ID: 37748629
[TBL] [Abstract][Full Text] [Related]
33. miR-223 regulates cell growth and targets proto-oncogenes in mycosis fungoides/cutaneous T-cell lymphoma.
McGirt LY; Adams CM; Baerenwald DA; Zwerner JP; Zic JA; Eischen CM
J Invest Dermatol; 2014 Apr; 134(4):1101-1107. PubMed ID: 24304814
[TBL] [Abstract][Full Text] [Related]
34. TOX expression in different subtypes of cutaneous lymphoma.
Morimura S; Sugaya M; Suga H; Miyagaki T; Ohmatsu H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
Arch Dermatol Res; 2014 Nov; 306(9):843-9. PubMed ID: 25216799
[TBL] [Abstract][Full Text] [Related]
35. Upregulation of inhibitory signaling receptor programmed death marker-1 (PD-1) in disease evolution from cutaneous lymphoid dyscrasias to mycosis fungoides and Sezary's syndrome.
Nguyen GH; Olson LC; Magro CM
Ann Diagn Pathol; 2017 Jun; 28():54-59. PubMed ID: 28648940
[TBL] [Abstract][Full Text] [Related]
36. Genomic analysis reveals recurrent deletion of JAK-STAT signaling inhibitors HNRNPK and SOCS1 in mycosis fungoides.
Bastidas Torres AN; Cats D; Mei H; Szuhai K; Willemze R; Vermeer MH; Tensen CP
Genes Chromosomes Cancer; 2018 Dec; 57(12):653-664. PubMed ID: 30144205
[TBL] [Abstract][Full Text] [Related]
37. Oncogenomic analysis identifies novel biomarkers for tumor stage mycosis fungoides.
Dong Z; Zhu X; Li Y; Gan L; Chen H; Zhang W; Sun J
Medicine (Baltimore); 2018 May; 97(21):e10871. PubMed ID: 29794791
[TBL] [Abstract][Full Text] [Related]
38. Mycosis fungoides shows concurrent deregulation of multiple genes involved in the TNF signaling pathway: an expression profile study.
Tracey L; Villuendas R; Dotor AM; Spiteri I; Ortiz P; Garcia JF; Peralto JL; Lawler M; Piris MA
Blood; 2003 Aug; 102(3):1042-50. PubMed ID: 12689942
[TBL] [Abstract][Full Text] [Related]
39. Expression and activity of IL-17 in cutaneous T-cell lymphomas (mycosis fungoides and Sezary syndrome).
Cirée A; Michel L; Camilleri-Bröet S; Jean Louis F; Oster M; Flageul B; Senet P; Fossiez F; Fridman WH; Bachelez H; Tartour E
Int J Cancer; 2004 Oct; 112(1):113-20. PubMed ID: 15305382
[TBL] [Abstract][Full Text] [Related]
40. Mycosis fungoides exhibits a Th1-type cell-mediated cytokine profile whereas Sezary syndrome expresses a Th2-type profile.
Saed G; Fivenson DP; Naidu Y; Nickoloff BJ
J Invest Dermatol; 1994 Jul; 103(1):29-33. PubMed ID: 8027577
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
